Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Feb-23 9:00 PM View:  | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Conversion | 2,905,610 | -- | -- | 100% 0 to 2.91M | |
| 16-Feb-23 9:00 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Private Purchase | 312,500 | $16.00 | $5,000,000.00 | 11% 2.91M to 3.22M | |
| 12-Nov-21 4:16 PM View: | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 2,365,540 | -- | -- | 100% 0 to 2.37M | |
| 12-Nov-21 4:16 PM View: | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase | 325,000 | $14.00 | $4,550,000.00 | 14% 2.37M to 2.69M | |
| 05-May-21 4:00 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 625,995 | -- | -- | 100% 0 to 626.0K | |
| 14-Sep-17 8:21 PM View: | Nabriva Therapeutics Plc (NBRV) | 14-Sep-17 | Market Sale | 3,429 | $8.52 | $29,223.70 | (< 1%) 2.34M to 2.33M | 97% |
| 14-Sep-17 8:21 PM View: | Nabriva Therapeutics Plc (NBRV) | 13-Sep-17 | Market Sale | 22,721 | $8.54 | $193,956.00 | (< 1%) 2.36M to 2.34M | 97% |
| 14-Sep-17 8:21 PM View: | Nabriva Therapeutics Plc (NBRV) | 12-Sep-17 | Market Sale | 10,458 | $8.63 | $90,235.80 | (< 1%) 2.37M to 2.36M | 97% |
| 05-Sep-17 8:18 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Aug-17 | Market Sale | 639 | $9.50 | $6,070.50 | (< 1%) 2.37M to 2.37M | 97% |
| 09-Aug-17 8:54 PM View: | Nabriva Therapeutics Plc (NBRV) | 08-Aug-17 | Market Sale | 2,013 | $10.50 | $21,137.10 | (< 1%) 2.37M to 2.37M | 97% |
| 09-Aug-17 8:54 PM View: | Nabriva Therapeutics Plc (NBRV) | 07-Aug-17 | Market Sale | 17,790 | $10.50 | $186,795.00 | (< 1%) 2.39M to 2.37M | 97% |
| 01-Aug-17 9:21 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Jul-17 | Market Sale | 6,585 | $10.51 | $69,195.20 | (< 1%) 2.4M to 2.39M | 97% |
| 26-Jul-17 9:03 PM View: | Nabriva Therapeutics Plc (NBRV) | 24-Jul-17 | Market Sale | 160 | $10.50 | $1,680.00 | (< 1%) 2.4M to 2.4M | 97% |
| 24-Jul-17 9:10 PM View: | Nabriva Therapeutics Plc (NBRV) | 20-Jul-17 | Market Sale | 23,445 | $10.50 | $246,172.00 | (< 1%) 2.42M to 2.4M | 97% |
| 21-Jul-17 9:36 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 20-Jul-17 | Market Sale | 23,445 | $10.50 | $246,172.00 | (< 1%) 2.42M to 2.4M | 86% |
| 24-Jul-17 9:10 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Jul-17 | Market Sale | 20,786 | $10.50 | $218,253.00 | (< 1%) 2.44M to 2.42M | 97% |
| 21-Jul-17 9:36 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 19-Jul-17 | Market Sale | 20,786 | $10.50 | $218,253.00 | (< 1%) 2.44M to 2.42M | 86% |
| 18-Jul-17 9:03 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 18-Jul-17 | Market Sale | 1,339 | $10.50 | $14,059.50 | (< 1%) 2.44M to 2.44M | 86% |
| 18-Jul-17 9:03 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 17-Jul-17 | Market Sale | 47,460 | $10.50 | $498,415.00 | (2%) 2.49M to 2.44M | 86% |
| 18-Jul-17 9:03 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 14-Jul-17 | Market Sale | 21,055 | $10.53 | $221,789.00 | (< 1%) 2.51M to 2.49M | 86% |
| 13-Jul-17 9:22 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 13-Jul-17 | Market Sale | 39,914 | $10.54 | $420,757.00 | (2%) 2.55M to 2.51M | 86% |
| 13-Jul-17 9:22 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 12-Jul-17 | Market Sale | 13,740 | $10.50 | $144,271.00 | (< 1%) 2.57M to 2.55M | 86% |
| 13-Jul-17 9:22 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 11-Jul-17 | Market Sale | 3,521 | $10.52 | $37,027.20 | (< 1%) 2.57M to 2.57M | 86% |
| 07-Jul-17 9:29 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 07-Jul-17 | Market Sale | 133 | $10.50 | $1,396.50 | (< 1%) 2.57M to 2.57M | 86% |
| 07-Jul-17 9:29 PM View: | Nabriva Therapeutics Legacy... (NBRV) | 05-Jul-17 | Market Sale | 2,562 | $10.52 | $26,960.40 | (< 1%) 2.57M to 2.57M | 86% |
| 05-Jul-17 8:58 PM View: | Nabriva Therapeutics Plc (NBRV) | 03-Jul-17 | Market Sale | 11,352 | $10.95 | $124,250.00 | (< 1%) 2.58M to 2.57M | 97% |
| 05-Jul-17 8:58 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Jun-17 | Market Sale | 1,775 | $10.94 | $19,420.50 | (< 1%) 2.59M to 2.58M | 97% |
| 29-Jun-17 9:33 PM View: | Nabriva Therapeutics Plc (NBRV) | 29-Jun-17 | Market Sale | 1,603 | $10.72 | $17,189.00 | (< 1%) 2.59M to 2.58M | 97% |
| 29-Jun-17 9:33 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Jun-17 | Market Sale | 4,789 | $11.10 | $53,157.90 | (< 1%) 2.59M to 2.59M | 97% |
| 29-Jun-17 9:33 PM View: | Nabriva Therapeutics Plc (NBRV) | 27-Jun-17 | Market Sale | 2,166 | $10.83 | $23,457.10 | (< 1%) 2.59M to 2.59M | 97% |
| 05-Jun-17 9:41 PM View: | Nabriva Therapeutics Plc (NBRV) | 01-Jun-17 | Market Sale | 400 | $11.27 | $4,508.00 | (< 1%) 2.59M to 2.59M | 98% |
| 28-Apr-17 7:13 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Apr-17 | Market Sale | 15,130 | $11.03 | $166,813.00 | (< 1%) 2.61M to 2.59M | 97% |
| 28-Apr-17 7:13 PM View: | Nabriva Therapeutics Plc (NBRV) | 27-Apr-17 | Market Sale | 100 | $11.00 | $1,100.00 | (< 1%) 2.61M to 2.61M | 97% |
| 28-Apr-17 7:13 PM View: | Nabriva Therapeutics Plc (NBRV) | 26-Apr-17 | Market Sale | 709 | $11.00 | $7,799.00 | (< 1%) 2.61M to 2.61M | 97% |
| 25-Apr-17 7:19 PM View: | Nabriva Therapeutics Plc (NBRV) | 21-Apr-17 | Market Sale | 2,622 | $11.04 | $28,937.40 | (< 1%) 2.61M to 2.61M | 97% |
| 20-Apr-17 8:29 PM View: | Nabriva Therapeutics Plc (NBRV) | 20-Apr-17 | Market Sale | 325 | $11.00 | $3,575.00 | (< 1%) 2.61M to 2.61M | 97% |
| 20-Apr-17 8:29 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Apr-17 | Market Sale | 11,785 | $11.07 | $130,434.00 | (< 1%) 2.62M to 2.61M | 97% |
| 20-Apr-17 8:29 PM View: | Nabriva Therapeutics Plc (NBRV) | 18-Apr-17 | Market Sale | 11,822 | $11.16 | $131,880.00 | (< 1%) 2.64M to 2.62M | 98% |
| 13-Apr-17 9:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 13-Apr-17 | Market Sale | 10,984 | $11.13 | $122,232.00 | (< 1%) 2.65M to 2.64M | 97% |
| 13-Apr-17 9:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 12-Apr-17 | Market Sale | 13,250 | $11.22 | $148,653.00 | (< 1%) 2.66M to 2.65M | 98% |
| 13-Apr-17 9:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 11-Apr-17 | Market Sale | 8,597 | $11.40 | $98,034.20 | (< 1%) 2.67M to 2.66M | 98% |
| 10-Apr-17 9:38 PM View: | Nabriva Therapeutics Plc (NBRV) | 10-Apr-17 | Market Sale | 37,876 | $10.73 | $406,451.00 | (17%) 223.27K to 185.39K | 97% |
| 10-Apr-17 9:38 PM View: | Nabriva Therapeutics Plc (NBRV) | 07-Apr-17 | Market Sale | 21,501 | $10.97 | $235,931.00 | (9%) 244.77K to 223.27K | 97% |
| 10-Apr-17 9:38 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Apr-17 | Market Sale | 31,217 | $11.22 | $350,160.00 | (11%) 275.99K to 244.77K | 98% |
| 01-Jun-15 8:36 PM View: | Novacea, Inc. (PRTK) | 29-May-15 | Market Sale | 10,000 | $29.79 | $297,908.00 | (< 1%) 1.76M to 1.75M | |
| 01-Jun-15 8:36 PM View: | Novacea, Inc. (PRTK) | 28-May-15 | Market Sale | 10,580 | $31.66 | $334,985.00 | (< 1%) 1.77M to 1.76M | |
| 15-May-14 5:10 PM View: | Iveric Bio, Inc. (ISEE) | 13-May-14 | Market Sale | 500,000 | $29.75 | $14,875,000.00 | (14%) 3.64M to 3.14M | 77% |
| 19-Dec-13 4:42 PM View: | Ptc Therapeutics, Inc. (PTCT) | 17-Dec-13 | Market Sale | 66,667 | $19.08 | $1,272,120.00 | (3%) 2.51M to 2.44M | (42%) |
| 03-Oct-13 5:51 PM View: | Iveric Bio, Inc. (ISEE) | 30-Sep-13 | Conversion | 3,411,900 | -- | -- | 341190000% 0 to 3.41M | |
| 03-Oct-13 5:51 PM View: | Iveric Bio, Inc. (ISEE) | 30-Sep-13 | Purchase | 228,000 | $22.00 | $5,016,000.00 | 7% 3.41M to 3.64M |